LINC00641 and gastric adenocarcinoma: Silencing LINC00641 reduces the proliferation, migration and invasion of cancer cells and induces apoptosis in gastric cancer cell lines (38), and LINC00641 participates in regulating oxaliplatin resistance by changing autophagy in gastric adenocarcinoma, providing a direction for the treatment of gastric cancer (45).